Publications
2023
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
Chaplin, M., Bresnahan, R., Fleeman, N., Mahon, J., Houten, R., Beale, S., . . . Munot, P. (2023). Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.. PharmacoEconomics - open, 7(6), 1015. doi:10.1007/s41669-023-00462-7
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15
Chaplin, M., Bresnahan, R., Fleeman, N., Mahon, J., Houten, R., Beale, S., . . . Munot, P. (2023). Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15. PharmacoEconomics - Open. doi:10.1007/s41669-023-00439-6
Cluster‐randomized controlled trials: A tutorial
Chaplin, M., & Dwan, K. (2023). Cluster‐randomized controlled trials: A tutorial. Cochrane Evidence Synthesis and Methods, 1(7). doi:10.1002/cesm.12024
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Bresnahan, R., Houten, R., Greenhalgh, J., Nevitt, S., Mahon, J., Beale, S., . . . Chaplin, M. (2023). Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.. PharmacoEconomics - open. doi:10.1007/s41669-023-00408-z
Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer [ID4031]
Greenhalgh, J., Mahon, J., Bryning, S., Chaplin, M., Beale, S., Boland, A., . . . Basu, B. (2023). Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer [ID4031]: Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer [ID4031]. Retrieved from https://www.nice.org.uk/guidance/gid-ta10920/documents/committee-papers
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Houten, R., Fleeman, N., Mahon, J., Chaplin, M., Edwards, K., Beale, S., . . . Palmieri, C. (2023). Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN. doi:10.1007/s41669-023-00405-2
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
Bresnahan, R., Duarte, R., Mahon, J., Beale, S., Chaplin, M., Bhattacharyya, D., . . . Boland, A. (2023). Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.. Health technology assessment (Winchester, England), 27(10), 1-115. doi:10.3310/kgju3398
2022
House modifications for preventing malaria.
Fox, T., Furnival-Adams, J., Chaplin, M., Napier, M., & Olanga, E. A. (2022). House modifications for preventing malaria.. The Cochrane database of systematic reviews, 10, CD013398. doi:10.1002/14651858.cd013398.pub4
Accuracy of measures for antiretroviral adherence in people living with HIV
Smith, R., Villanueva, G., Probyn, K., Sguassero, Y., Ford, N., Orrell, C., . . . Hine, P. (2022). Accuracy of measures for antiretroviral adherence in people living with HIV. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD013080.pub2
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Pillay, S., Steingart, K. R., Davies, G. R., Chaplin, M., De Vos, M., Schumacher, S. G., . . . Theron, G. (2022). Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD014841.pub2
Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.
Naude, C. E., Brand, A., Schoonees, A., Nguyen, K. A., Chaplin, M., & Volmink, J. (2022). Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.. The Cochrane database of systematic reviews, 1, CD013334. doi:10.1002/14651858.cd013334.pub2
2021
Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
Nathavitharana, R. R., Lederer, P., Chaplin, M., Bjerrum, S., Steingart, K. R., & Shah, M. (2021). Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.. The Cochrane database of systematic reviews, 8, CD014641. doi:10.1002/14651858.cd014641
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Pillay, S., Davies, G. R., Chaplin, M., De Vos, M., Schumacher, S. G., Warren, R., . . . Theron, G. (n.d.). Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. Cochrane Database of Systematic Reviews, 2021(6). doi:10.1002/14651858.cd014841
Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa
Gleave, K., Lissenden, N., Chaplin, M., Choi, L., & Ranson, H. (2021). Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD012776.pub3
Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection.
Anton-Vazquez, V., Hine, P., Krishna, S., Chaplin, M., & Planche, T. (2021). Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection.. The Cochrane database of systematic reviews, 5, CD013235. doi:10.1002/14651858.cd013235.pub2
First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer
Greenhalgh, J., Boland, A., Bates, V., Vecchio, F., Dundar, Y., Chaplin, M., & Green, J. A. (2021). First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD010383.pub3
Improving the Reporting of Pharmacogenetic Studies to Facilitate Evidence Synthesis: Anti-Tuberculosis Drug-Related Toxicity as an Example
Chaplin, M. (2021, March 11). Improving the Reporting of Pharmacogenetic Studies to Facilitate Evidence Synthesis: Anti-Tuberculosis Drug-Related Toxicity as an Example.
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. (2021). Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD013587.pub2
Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria
Weeratunga, P., Bancone, G., Ochodo, E. A., Pant, S., Thapa, J., & Chaplin, M. (n.d.). Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013861
2020
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Stainthorpe, A., Fleeman, N., Houten, R., Chaplin, M., Boland, A., Beale, S., . . . Syndikus, I. (2020). Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 4(4), 563-574. doi:10.1007/s41669-020-00203-0
STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline
Chaplin, M., Kirkham, J. J., Dwan, K., Sloan, D. J., Davies, G., & Jorgensen, A. L. (2020). STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline. PLOS MEDICINE, 17(9). doi:10.1371/journal.pmed.1003344
Rapid diagnostic tests for plague.
Jullien, S., Dissanayake, H. A., & Chaplin, M. (2020). Rapid diagnostic tests for plague.. The Cochrane database of systematic reviews, 6, CD013459. doi:10.1002/14651858.cd013459.pub2
High-intensity interval training for reducing cardiometabolic syndrome in healthy but sedentary populations
Strauss, J. A., Ranasinghe, C., Cowley, E., Schwingshackl, L., Shepherd, S. O., Chaplin, M., & Garner, P. (n.d.). High-intensity interval training for reducing cardiometabolic syndrome in healthy but sedentary populations. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013617
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. (n.d.). Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013587
Ixekizumab for treating axial spondyloarthritis after NSAIDs [ID1532]
Greenhalgh, J., Fleeman, N., Houten, R., Chaplin, M., Beale, S., Boland, A., . . . Goodson, N. (2020). Ixekizumab for treating axial spondyloarthritis after NSAIDs [ID1532]: Ixekizumab for treating axial spondyloarthritis after NSAIDs[ID1532]. Retrieved from https://www.liverpool.ac.uk/population-health/staff/janette-greenhalgh/
Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
Duarte, R., Stainthorpe, A., Greenhalgh, J., Richardson, M., Nevitt, S., Mahon, J., . . . Takwoingi, Y. (2020). Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24(3), 1-+. doi:10.3310/hta24030
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
Fleeman, N., Houten, R., Bagust, A., Richardson, M., Beale, S., Boland, A., . . . Shenoy, A. (2020). Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24(2), 1-+. doi:10.3310/hta24020
2019
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine
Fleeman, N., Houten, R., Chaplin, M., Beale, S., Boland, A., Dundar, Y., . . . Shenoy, A. (2019). A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC CANCER, 19(1). doi:10.1186/s12885-019-6369-7
Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation
Duarte, R., Stainthorpe, A., Mahon, J., Greenhalgh, J., Richardson, M., Nevitt, S., . . . Takwoingi, Y. (2019). Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation. PLOS ONE, 14(12). doi:10.1371/journal.pone.0226671
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Fleeman, N., Bagust, A., Duarte, R., Richardson, M., Nevitt, S., Boland, A., . . . Thorp, N. (2019). Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 3(3), 293-302. doi:10.1007/s41669-018-0114-z
Pembrolizumab for untreated recurrent or metastatic squamous cell carcinoma of the head and neck
Greenhalgh, J., Mahon, J., Chaplin, M., Nevitt, S., Boland, A., Beale, S., . . . Shaw, R. (2019). Pembrolizumab for untreated recurrent or metastatic squamous cell carcinoma of the head and neck: Pembrolizumab for untreated recurrent or metastatic squamous cell carcinoma of the head and neck (17/56/06). NICE website. Retrieved from https://www.nice.org.uk/guidance/gid-ta10181/documents/committee-papers
Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies
Richardson, M., Kirkham, J. J., Dwan, K. M., Sloan, D. J., Davies, G., & Jorgensen, A. (2019). Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies. BMJ OPEN, 9(7). doi:10.1136/bmjopen-2019-030212
Atezolizumab for untreated, locally advanced or metastatic, triple negative breast cancer
Greenhalgh, J., Mahon, J., Chaplin, M., Beale, S., Boland, A., Lambe, T., . . . Palmieri, C. (2019). Atezolizumab for untreated, locally advanced or metastatic, triple negative breast cancer: Atezolizumab for untreated, locally advanced or metastatic, triple negative breast cancer (128748). NICE website. Retrieved from https://www.nice.org.uk/guidance/gid-ta10433/documents/committee-papers
Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk
Naude, C. E., Schoonees, A., Nguyen, K. A., Senekal, M., Young, T., Garner, P., . . . Volmink, J. (n.d.). Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013334
NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis
Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G., & Jorgensen, A. L. (2019). NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 23(3), 293-305. doi:10.5588/ijtld.18.0324
Association of variants within the <i>GST</i> and other genes with anti-tubercular agents related toxicity: a systematic review and meta-analysis
Richardson, M., Kirkham, J., Dwan, K., Sloan, D., Davies, G., & Jorgensen, A. (2019). Association of variants within the <i>GST</i> and other genes with anti-tubercular agents related toxicity: a systematic review and meta-analysis. doi:10.1101/515817
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis
Macfarlane, C. L., Budhathoki, S. S., Johnson, S., Richardson, M., & Garner, P. (2019). Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD003753.pub4
2018
Rapid versus standard antibiotic susceptibility testing for treating bloodstream infections
Anton-Vazquez, V., Hine, P., Krishna, S., Richardson, M., & Planche, T. (n.d.). Rapid versus standard antibiotic susceptibility testing for treating bloodstream infections. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013235
Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa.
Gleave, K., Lissenden, N., Richardson, M., Choi, L., & Ranson, H. (2018). Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa.. The Cochrane database of systematic reviews, 11, CD012776. doi:10.1002/14651858.cd012776.pub2
<i>CYP</i> genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis
Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G., & Jorgensen, A. L. (2018). <i>CYP</i> genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis. SYSTEMATIC REVIEWS, 7. doi:10.1186/s13643-018-0861-z
Osimertinib for untreated epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer
Fleeman, N., Mahon, J., Chaplin, M., Boland, A., Beale, S., De Sousa Rego Vieira Duarte, R., . . . Green, J. (2018). Osimertinib for untreated epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer: Osimertinib for untreated epidermal growth factor receptor (EGFR) mutation-positive non- small-cell lung cancer (17/141/08). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta621/documents/committee-papers
Insecticide-treated nets for preventing malaria
Pryce, J., Richardson, M., & Lengeler, C. (2018). Insecticide-treated nets for preventing malaria. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11). doi:10.1002/14651858.CD000363.pub3
Insecticide-treated nets for preventing malaria.
Pryce, J., Richardson, M., & Lengeler, C. (2018). Insecticide-treated nets for preventing malaria.. The Cochrane database of systematic reviews, 11, CD000363. doi:10.1002/14651858.cd000363.pub3
Insecticide space spraying for preventing malaria transmission
Pryce, J., Choi, L., Richardson, M., & Malone, D. (2018). Insecticide space spraying for preventing malaria transmission. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11). doi:10.1002/14651858.CD012689.pub2
Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12)
Fleeman, N., Stainthorpe, A., Houten, R., Chaplin, M., Boland, A., Beale, S., . . . Isabel, S. (2018). Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12): Brentuximab vedotin for treating relapsed or refractory CD30- positive cutaneous T-cell lymphoma (17/56/12). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta577/documents/committee-papers
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Stainthorpe, A., Greenhalgh, J., Bagust, A., Richardson, M., Boland, A., Beale, S., . . . Palmer, D. (2018). Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(10), 1153-1163. doi:10.1007/s40273-018-0646-1
Drugs for treating Buruli ulcer (<i>Mycobacterium ulcerans</i> disease)
Yotsu, R. R., Richardson, M., & Ishii, N. (2018). Drugs for treating Buruli ulcer (<i>Mycobacterium ulcerans</i> disease). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (8). doi:10.1002/14651858.CD012118.pub2
Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis
Eshun-Wilson, I., Okwen, M. P., Richardson, M., & Bicanic, T. (2018). Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD009012.pub3
Vaccines for preventing typhoid fever (Review)
Milligan, R., Paul, M., Richardson, M., & Neuberger, A. (2018). Vaccines for preventing typhoid fever (Review). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD001261.pub4
Interpretation of subgroup analyses in systematic reviews: A tutorial
Richardson, M., Garner, P., & Donegan, S. (2018). Interpretation of subgroup analyses in systematic reviews: A tutorial. Clinical Epidemiology and Global Health. doi:10.1016/j.cegh.2018.05.005
A systematic review of the diagnostic accuracy of automated tests for cognitive impairment
Aslam, R. W., Bates, V., Dundar, Y., Hounsome, J., Richardson, M., Krishan, A., . . . Sikdar, S. (2018). A systematic review of the diagnostic accuracy of automated tests for cognitive impairment. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 33(4), 561-575. doi:10.1002/gps.4852
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Fleeman, N., Abdulla, A., Bagust, A., Beale, S., Richardson, M., Stainthorpe, A., . . . Palmer, D. (2018). Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 36(3), 289-299. doi:10.1007/s40273-017-0592-3
Mosquito repellents for malaria prevention
Maia, M. F., Kliner, M., Richardson, M., Lengeler, C., & Moore, S. J. (2018). Mosquito repellents for malaria prevention. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD011595.pub2
Development of reporting guidelines for pharmacogenetic studies to facilitate evidence synthesis
Richardson, M., Kirkham, J., Dwan, K., Sloan, D., Davies, G., & Jorgensen, A. (2018). Development of reporting guidelines for pharmacogenetic studies to facilitate evidence synthesis. In GENETIC EPIDEMIOLOGY Vol. 42 (pp. 727). Retrieved from https://www.webofscience.com/
Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa
Gleave, K., Lissenden, N., Richardson, M., Choi, L., & Ranson, H. (2018). Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11). doi:10.1002/14651858.C0012776.pub2
2017
Eribulin for treating locally advanced or metastatic breast cancer after one prior chemotherapy regimen
Fleeman, N., Bagust, A., Duarte, R., Chaplin, M., Nevitt, S., Boland, A., . . . Thorp, N. (n.d.). Eribulin for treating locally advanced or metastatic breast cancer after one prior chemotherapy regimen (ID1072). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta515/documents/committee-papers
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Fleeman, N., Bagust, A., Boland, A., Beale, S., Richardson, M., Krishan, A., . . . Payne, M. (2017). Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 35(10), 1035-1046. doi:10.1007/s40273-017-0504-6
Piperonyl butoxide (PBO) combined with pyrethroids in long-lasting insecticidal nets (LLINs) to prevent malaria in Africa
Gleave, K., Lissenden, N., Richardson, M., & Ranson, H. (n.d.). Piperonyl butoxide (PBO) combined with pyrethroids in long-lasting insecticidal nets (LLINs) to prevent malaria in Africa. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd012776
Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
Uthman, O. A., Graves, P. M., Saunders, R., Gelband, H., Richardson, M., & Garner, P. (2017). Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies. MALARIA JOURNAL, 16. doi:10.1186/s12936-017-1989-3
Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer
Greenhalgh, J. (n.d.). Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer (ID1059). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta535/documents/committee-papers
Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)
Richardson, M. H., Kirkham, J., Dwan, K., Sloan, D., Davies, G., & Jorgensen, A. (2017). Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol). Systematic Reviews. doi:10.1186/s13643-017-0533-4
Nab-paclitaxel with gemcitabine for 1st line metastatic pancreatic adenocarcinoma
Greenhalgh, J. (n.d.). Nab-paclitaxel with gemcitabine for 1st line metastatic pancreatic adenocarcinoma (ID1058). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta476/documents/committee-papers
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer
Greenhalgh, J., Bagust, A., Stainthorpe, A., Chaplin, M., Boland, A., De Sousa Rego Vieira Duarte, R., . . . Palmer, D. (2017). Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer: Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (14/90/01). NICE website. Retrieved from https://www.nice.org.uk/guidance/ta476/documents/committee-papers
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after platinum-based chemotherapy
Greenhalgh, J. (n.d.). Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after platinum-based chemotherapy (ID970). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta520/documents/committee-papers
Atezolizumab for the treatment of people with locally advanced or metastatic non-small lung cancer whose disease has progressed after chemotherapy
Beale, S., Mahon, J., Nevitt, S., Boland, A., Greenhalgh, J., Richardson, M., . . . Green, J. (2017). Atezolizumab for the treatment of people with locally advanced or metastatic non-small lung cancer whose disease has progressed after chemotherapy (ID970).
Crizotinib for treating ROS1positive advanced non-small cell lung cancer
Greenhalgh, J., Stainthorpe, S., Richardson, M., Duarte, R., Boland, A., Kotas, E., . . . Green, J. (2017). Crizotinib for treating ROS1positive advanced non-small cell lung cancer (D1098).
2016
Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer
Greenhalgh, J. (n.d.). Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer (ID915). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta495/documents/committee-papers-2
Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review
Aslam, R. W., Bates, V., Dundar, Y., Hounsome, J., Richardson, M., Krishan, A., . . . Robinson, L. (2016). Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health Technology Assessment, 20(77). doi:10.3310/hta20770
Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review
Aslam, R. W., Bates, V., Dundar, Y., Hounsome, J., Richardson, M., Krishan, A., . . . Robinson, L. (2016). Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health technology assessment (Winchester, England), 20(77), 1-74.
GenoType® MTBDR<i>sl</i> assay for resistance to second-line anti-tuberculosis drugs
Theron, G., Peter, J., Richardson, M., Warren, R., Dheda, K., & Steingart, K. R. (2016). GenoType® MTBDR<i>sl</i> assay for resistance to second-line anti-tuberculosis drugs. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD010705.pub3
Eribulin for locally advanced or metastatic breast cancer
Greenhalgh, J. (n.d.). Eribulin for locally advanced or metastatic breast cancer (ID964). NICE Website. Retrieved from https://www.nice.org.uk/guidance/gid-ta10030/documents/committee-papers
Nanoliposomal irinotecan for treating pancreatic cancer after prior treatment with gemcitabine
Greenhalgh, J. (n.d.). Nanoliposomal irinotecan for treating pancreatic cancer after prior treatment with gemcitabine (ID778). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta440/documents/committee-papers-2
Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis
Dundar, Y., Greenhalgh, J., Richardson, M., & Dwan, K. (2016). Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 31(4), 268-285. doi:10.1002/hup.2535
Integrated management of childhood illness (IMCI) strategy for children under five
Gera, T., Shah, D., Garner, P., Richardson, M., & Sachdev, H. S. (2016). Integrated management of childhood illness (IMCI) strategy for children under five. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD010123.pub2
Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes
Kelly, C., Gaskell, K. M., Richardson, M., Klein, N., Garner, P., & MacPherson, P. (2016). Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes. PLOS ONE, 11(6). doi:10.1371/journal.pone.0156099
The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
Fleeman, N., Mahon, J., Bates, V., Dickson, R., Dundar, Y., Dwan, K., . . . Shaw, B. N. J. (2016). The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 20(30), 1-67. doi:10.3310/hta20300
Cluster Randomised Trials in Cochrane Reviews: Evaluation of Methodological and Reporting Practice
Richardson, M., Garner, P., & Donegan, S. (2016). Cluster Randomised Trials in Cochrane Reviews: Evaluation of Methodological and Reporting Practice. PLOS ONE, 11(03), 14 pages. doi:10.1371/journal.pone.0151818
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
Yotsu, R. R., Richardson, M., & Ishii, N. (n.d.). Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd012118
Nivolumab for treating metastatic, non-squamous, non-small-cell lung cancer after chemotherapy
Greenhalgh, J. (n.d.). Nivolumab for treating metastatic, non-squamous, non-small-cell lung cancer after chemotherapy (ID900). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta484/documents/committee-papers
Trametinib in combination with dabrafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma
Greenhalgh, J., Mahon, J., Beale, S., Boland, A., Krishan, A., Chaplin, M., . . . Steven, N. (2016). Trametinib in combination with dabrafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma: Trametinib in combination with dabrafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma (12/50/01). NICE website. Retrieved from https://www.nice.org.uk/guidance/ta396/history
Talimogene laherparepvec for treating metastatic melanoma
Fleeman, N., Bagust, A., Boland, A., Beale, S., Chaplin, M., Krishan, A., . . . Payne, M. (2016). Talimogene laherparepvec for treating metastatic melanoma: Talimogene laherparepvec for treating metastatic melanoma (14/206/04). NICE Website. Retrieved from https://www.nice.org.uk/guidance/gid-tag509/documents/committee-papers-2
2015
Health system and community level interventions for improving antenatal care coverage and health outcomes
Mbuagbaw, L., Medley, N., Darzi, A. J., Richardson, M., Garga, K. H., & Ongolo-Zogo, P. (2015). Health system and community level interventions for improving antenatal care coverage and health outcomes. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD010994.pub2
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective
Fleeman, N., Bagust, A., Beale, S., Boland, A., Dickson, R., Dwan, K., . . . Banks, L. (2015). Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective. PHARMACOECONOMICS, 33(9), 893-904. doi:10.1007/s40273-015-0276-9
Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab
Fleeman, N., Bagust, A., Chaplin, M., Krishan, A., Boland, A., Beale, S., . . . Payne, M. (2015). Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab: Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab (14/177/07). NICE Website. Retrieved from https://www.nice.org.uk/
Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study
Kliner, M., Canaan, M., Ndwandwe, S. Z., Busulwa, F., Welfare, W., Richardson, M., . . . Wright, J. (2015). Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study. INFECTIOUS DISEASES OF POVERTY, 4. doi:10.1186/s40249-015-0059-8
A mismatch between population health literacy and the complexity of health information: an observational study
Rowlands, G., Protheroe, J., Winkley, J., Richardson, M., Seed, P. T., & Rudd, R. (2015). A mismatch between population health literacy and the complexity of health information: an observational study. BRITISH JOURNAL OF GENERAL PRACTICE, 65(635), E379-E386. doi:10.3399/bjgp15X685285
Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab
Greenhalgh, J., Mahon, J., Chaplin, M., Krishan, A., Aslam, R., Beale, S., . . . Payne, M. (2015). Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab: Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab (14/177/06). NICE website. Retrieved from https://www.nice.org.uk/guidance/TA366/documents/committee-papers
Mosquito repellents for malaria prevention
Maia, M. F., Kliner, M., Richardson, M., Lengeler, C., & Moore, S. J. (n.d.). Mosquito repellents for malaria prevention. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011595
Edoxaban tosylate for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
Greenhalgh, J., Longworth, L., Crossan, C., Singh, J., Bagust, A., Boland, A., . . . Hall, M. (2015). Edoxaban tosylate for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: Edoxaban tosylate for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (14/14/01). NICE website. Retrieved from https://www.nice.org.uk/
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation
Greenhalgh, J., Bagust, A., Boland, A., Dwan, K., Beale, S., Hockenhull, J., . . . Marshall, E. (2015). Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 19(47), I-133. doi:10.3310/hta19470
Moderators of the effect of psychological interventions on depression and anxiety in cardiac surgery patients: A systematic review and meta-analysis
Protogerou, C., Fleernan, N., Dwan, K., Richardson, M., Dundar, Y., & Hagger, M. S. (2015). Moderators of the effect of psychological interventions on depression and anxiety in cardiac surgery patients: A systematic review and meta-analysis. BEHAVIOUR RESEARCH AND THERAPY, 73, 151-164. doi:10.1016/j.brat.2015.08.004
Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis
Greenhalgh, J., Bagust, A., Boland, A., Dwan, K., Beale, S., Fleeman, N., . . . Fisher, M. (2015). Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis. HEALTH TECHNOLOGY ASSESSMENT, 19(29), 1-+. doi:10.3310/hta19290
2014
The diagnostic accuracy of the GenoType® MTBDR<i>sl</i> assay for the detection of resistance to second-line anti-tuberculosis drugs
Theron, G., Peter, J., Richardson, M., Barnard, M., Donegan, S., Warren, R., . . . Dheda, K. (2014). The diagnostic accuracy of the GenoType® MTBDR<i>sl</i> assay for the detection of resistance to second-line anti-tuberculosis drugs. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD010705.pub2
Nintedanib for previously treated locally advanced or metastatic non small cell lung cancer
Fleeman, N., Bagust, A., Boland, A., Dwan, K., Chaplin, M., Beale, S., . . . Greystoke, A. (2014). Nintedanib for previously treated locally advanced or metastatic non small cell lung cancer: Nintedanib for previously treated locally advanced or metastatic non-small cell lung cancer (13/106/01). NICE Website. Retrieved from https://www.nice.org.uk/
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
Greenhalgh, J., Bagust, A., Beale, S., Boland, A., Chaplin, M., Dwan, K., . . . Hall, M. (2014). Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism: Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (14/15/01). NICE website. Retrieved from https://www.nice.org.uk/
Dabrafenib for treating unresectable, advanced or metastatic BRAFv600 mutation- positive melanoma
Fleeman, N., Bagust, A., Beale, S., Boland, A., Dickson, R., Dwan, K., . . . Banks, L. (2014). Dabrafenib for treating unresectable, advanced or metastatic BRAFv600 mutation- positive melanoma: Dabrafenib for treating unresectable, advanced or metastatic BRAFv600 mutation- positive melanoma (12/54). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta321/history
EFFICACY OF PSYCHOLOGICAL INTERVENTIONS TO REDUCE DISTRESS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES: A META-ANALYSIS
Protogerou, C., Fleeman, N. F., Dwain, K. D., Richardson, M. R., Dundar, Y. D., & Dickson, R. D. (2014). EFFICACY OF PSYCHOLOGICAL INTERVENTIONS TO REDUCE DISTRESS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES: A META-ANALYSIS. In INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE Vol. 21 (pp. S63). Retrieved from https://www.webofscience.com/